I finished listening to the full video and, as an aside, let me say that I found Maria Zeee's intellect and interviewing skills to be extremely impressive. In addition, Geert suggested that she interview Matias Desmet, and not only has she already done that, she had another interview already scheduled with him. Here's a snapshot.
And you're right. Things could become really ugly by the end of the year, as Geert suggested, and noted that infections are increasing already, well ahead of the winter months. It's fascinating to think that the increased transmissibility may be due to the virus being carried by non-neutralizing antibodies in vaccinated people, and that as a group, the vaccinees are more subject to a poor prognosis for infection from continuing variants.
I do have to say, though, that Geert's promotion of massive antiviral campaigns fails to account for the speed at which our investigative doctors noted the onset of cytokine storm. The only antiviral that I can think of that also mitigates cytokine storm is Innovative's brilacidin. But lenz not only treats cytokine storm, it also prevents its progression. Brilacidin is still in clinical trials, and the market has completely ignored a recent peer review in this regard.
But, the scenario Geert describes of a massive increase in virulence leading to a threat to our medical resource capabilities can't be ignored. Governments have to be prepared to meet this threat, and lenz is the best way to do that.
News 
Market Data 
Discover 
